Log In
Print
BCIQ
Print
Print this Print this
 

Zykadia, Ceritinib (LDK378)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionOral small molecule anaplastic lymphoma kinase (ALK) inhibitor
Molecular Target Anaplastic lymphoma kinase (ALK)
Mechanism of ActionAnaplastic lymphoma kinase (ALK) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today